Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leeder

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1984
Ceftazidime disposition in acute and stable cystic fibrosisJ S Leeder, M Spino, A F Isles, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Investigation of terbinafine as a CYP2D6 inhibitor in vivoS M Abdel-Rahman, R R Gotschall, R E Kauffman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2016
Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver MicrosomesJennifer L Goldman, Yakov M Koen, Steven A Rogers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafineS M Abdel-Rahman, K Marcucci, T Boge, et al.
Canadian Journal of Physiology and Pharmacology|November 8, 2001
Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populationsA Gaedigk, W L Casley, R F Tyndale, et al.
Pharmacogenetics|January 14, 2000
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency dataA Gaedigk, R R Gotschall, N S Forbes, et al.
Clinical Pharmacokinetics|July 1, 1985
Cerebrospinal fluid pharmacokinetics of tobramycin, ceftazidime, phenobarbitone and phenytoin in a childG Koren, S Lavi, M Greenwald, et al.
Leukemia & Lymphoma|September 1, 1992
Growth of human lymphoma cells in SCID miceH Chang, S Leeder, V A Cook, et al.
Clinical Pharmacology and Therapeutics|November 1, 2007
The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotypeA Gaedigk, S D Simon, R E Pearce, et al.
Pharmacogenetics|September 10, 1998
NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populationsA Gaedigk, R F Tyndale, M Jurima-Romet, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|September 1, 1984
Ceftazidime disposition in acute and stable cystic fibrosisJ S Leeder, M Spino, A F Isles, et al.
Clinical Pharmacology and Therapeutics|May 26, 1999
Investigation of terbinafine as a CYP2D6 inhibitor in vivoS M Abdel-Rahman, R R Gotschall, R E Kauffman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 2016
Bioactivation of Trimethoprim to Protein-Reactive Metabolites in Human Liver MicrosomesJennifer L Goldman, Yakov M Koen, Steven A Rogers, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 29, 1999
Potent inhibition of cytochrome P-450 2D6-mediated dextromethorphan O-demethylation by terbinafineS M Abdel-Rahman, K Marcucci, T Boge, et al.
Canadian Journal of Physiology and Pharmacology|November 8, 2001
Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populationsA Gaedigk, W L Casley, R F Tyndale, et al.
Pharmacogenetics|January 14, 2000
Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency dataA Gaedigk, R R Gotschall, N S Forbes, et al.
Clinical Pharmacokinetics|July 1, 1985
Cerebrospinal fluid pharmacokinetics of tobramycin, ceftazidime, phenobarbitone and phenytoin in a childG Koren, S Lavi, M Greenwald, et al.
Leukemia & Lymphoma|September 1, 1992
Growth of human lymphoma cells in SCID miceH Chang, S Leeder, V A Cook, et al.
Clinical Pharmacology and Therapeutics|November 1, 2007
The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotypeA Gaedigk, S D Simon, R E Pearce, et al.
Pharmacogenetics|September 10, 1998
NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populationsA Gaedigk, R F Tyndale, M Jurima-Romet, et al.
Pageof 13